MASLD, MLA Pesarattu and Other Developments
- PMID: 39720265
- PMCID: PMC11663955
- DOI: 10.1016/j.jceh.2024.102465
MASLD, MLA Pesarattu and Other Developments
Similar articles
-
Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Health Sci Rep. 2025 Jun 18;8(6):e70920. doi: 10.1002/hsr2.70920. eCollection 2025 Jun. Health Sci Rep. 2025. PMID: 40535518 Free PMC article.
-
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021).United European Gastroenterol J. 2025 Jul 3. doi: 10.1002/ueg2.70072. Online ahead of print. United European Gastroenterol J. 2025. PMID: 40605557
-
Comparable Long-Term Liver Transplant Outcomes in PSC with and without MASLD: Last Decade Analysis of the UNOS Database.Dig Dis. 2025 Jul 4:1-26. doi: 10.1159/000547227. Online ahead of print. Dig Dis. 2025. PMID: 40618753
-
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis.World J Cardiol. 2025 Jun 26;17(6):106147. doi: 10.4330/wjc.v17.i6.106147. World J Cardiol. 2025. PMID: 40575425 Free PMC article. Review.
-
Lipogenesis and MASLD: re-thinking the role of SREBPs.Arch Toxicol. 2025 Jun;99(6):2299-2312. doi: 10.1007/s00204-025-04052-w. Epub 2025 May 6. Arch Toxicol. 2025. PMID: 40327083 Review.
References
-
- Etymology. Cambridge dictionary. Available at: The Study of the Origin and History of Words, or a Study of This Type Relating to One Particular Word: available at https://dictionary.cambridge.org/dictionary/etymology, accessed on 04 Oct 24.
Publication types
LinkOut - more resources
Full Text Sources